Pliant Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:PLRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
10 Jul 24	SellUS$126,131	Keith Cummings	Individual		10,911	US$11.56
10 Jul 24	SellUS$447,488	Bernard Coulie	Individual		38,710	US$11.56

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PLRX?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,777,501	2.74%
VC/PE Firms	5,972,257	9.2%
Hedge Funds	6,301,977	9.7%
Institutions	50,899,042	78.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 87.38% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.81%	Deep Track Capital, LP	5,972,257	US$78.9m	0%	2.52%
8.58%	BlackRock, Inc.	5,218,965	US$68.9m	4.97%	no data
7.94%	T. Rowe Price Group, Inc.	4,834,813	US$63.9m	5.05%	0.01%
6.38%	FMR LLC	3,880,690	US$51.3m	-0.27%	no data
5.8%	The Vanguard Group, Inc.	3,526,514	US$46.6m	2.6%	no data
5.25%	Redmile Group, LLC	3,197,491	US$42.2m	-0.38%	2.4%
5.1%	Paradigm Biocapital Advisors LP	3,104,486	US$41.0m	0%	1.54%
4.94%	CHI Advisors LLC	3,004,199	US$39.7m	0%	18.49%
3.5%	Third Rock Ventures, LLC	2,132,867	US$28.2m	0%	6.03%
3.31%	Polar Capital Holdings Plc	2,015,000	US$26.6m	0%	0.1%
3.14%	Great Point Partners, LLC	1,910,121	US$25.2m	-27.6%	9.94%
3.08%	First Light Asset Management, LLC	1,875,467	US$24.8m	-44.9%	2.27%
2.52%	Deutsche Asset & Wealth Management	1,534,365	US$20.3m	0.54%	0.01%
2.31%	State Street Global Advisors, Inc.	1,402,730	US$18.5m	1.93%	no data
2.17%	Geode Capital Management, LLC	1,318,308	US$17.4m	2.43%	no data
2.11%	RA Capital Management, L.P.	1,281,000	US$16.9m	0%	0.21%
2.1%	Pictet Asset Management Limited	1,279,717	US$16.9m	7.02%	0.01%
1.69%	Franklin Resources, Inc.	1,027,390	US$13.6m	0.32%	no data
1.37%	Candriam, Société En Commandite Par Actions	833,216	US$11.0m	0%	0.03%
1.28%	Morgan Stanley, Investment Banking and Brokerage Investments	780,136	US$10.3m	20.6%	no data
1.21%	Granahan Investment Management, LLC	738,252	US$9.8m	-24.8%	0.37%
1.1%	Bernard Coulie	666,570	US$8.8m	6.11%	no data
1.03%	Bank of America Corporation, Asset Management Arm	626,696	US$8.3m	3.89%	no data
0.84%	Fernwood Investment Management, LLC	513,136	US$6.8m	3.4%	2.13%
0.82%	Northern Trust Global Investments	502,016	US$6.6m	5.21%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 09:53
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pliant Therapeutics, Inc. is covered by 17 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Edward Nash	Canaccord Genuity
Pete Stavropoulos	Cantor Fitzgerald & Co.
David Lebowitz	Citigroup Inc